Active ingredientClofedanolCat. No. P-C206-001CAS 791-35-5Family · Pharmaceutical analytical standards
Clofedanol
A centrally acting cough suppressant for dry cough, it was marketed in several countries including Canada, Japan, Germany and Spain; in the United States it was accepted as an over-the-counter medicine in 1987. This family brings together the active ingredient, metabolites, labelled standards and nitrosamines.
Did you know?It does more than calm the cough reflex: it also has local anaesthetic, antispasmodic and antihistamine properties, and unlike dextromethorphan it binds poorly to the sigma-1 receptor.
Go to the active ingredient →Active ingredientClofedanolCat. No. P-C206-001CAS 791-35-5
Active ingredientClofedanol HClCat. No. P-C206-002CAS 511-13-7
MetaboliteClofedanol-D-glucuronideCat. No. P-C206-003CAS 66171-85-5
Isotopically labelledClofedanol-d5Cat. No. P-C206-004
NitrosamineN-Nitroso-Desmethyl ClofedanolCat. No. P-C206-005No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.